1. Home
  2. DRTS vs BHK Comparison

DRTS vs BHK Comparison

Compare DRTS & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$7.52

Market Cap

641.6M

Sector

Health Care

ML Signal

HOLD

Logo Blackrock Core Bond Trust

BHK

Blackrock Core Bond Trust

HOLD

Current Price

$9.14

Market Cap

668.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
BHK
Founded
2015
2001
Country
Israel
United States
Employees
121
N/A
Industry
Medical/Dental Instruments
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
641.6M
668.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DRTS
BHK
Price
$7.52
$9.14
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
330.6K
221.8K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
8.34%
EPS Growth
N/A
N/A
EPS
N/A
1.03
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$699.98
N/A
P/E Ratio
N/A
$8.94
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$8.94
52 Week High
$8.80
$10.58

Technical Indicators

Market Signals
Indicator
DRTS
BHK
Relative Strength Index (RSI) 48.11 42.16
Support Level $6.47 $9.03
Resistance Level $7.75 $9.69
Average True Range (ATR) 0.56 0.06
MACD -0.02 -0.01
Stochastic Oscillator 19.00 17.02

Price Performance

Historical Comparison
DRTS
BHK

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About BHK Blackrock Core Bond Trust

Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.

Share on Social Networks: